Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
复制标题
DOI:
10.1111/j.1365-2141.2010.08424.x
复制
发表时间:
2011-05
影响因子:
6.5
通讯作者:
Rothman N
中科院分区:
文献类型:
--
作者:
Lan Q;Wang SS;Menashe I;Armstrong B;Zhang Y;Hartge P;Purdue MP;Holford TR;Morton LM;Kricker A;Cerhan JR;Grulich A;Cozen W;Zahm SH;Yeager M;Vajdic CM;Schenk M;Leaderer B;Yuenger J;Severson RK;Chatterjee N;Chanock SJ;Zheng T;Rothman N
The balance between Th1 and Th2 activity is critical in lymphoid cell development and differentiation. Immune dysfunction underlies lymphomagenesis, so an alteration in the regulation of key Th1/Th2 cytokines may lead to the development of non-Hodgkin lymphoma (NHL). To study the impact of polymorphism in Th1/Th2 cytokines on NHL risk, we analyzed 145 tag single nucleotide polymorphisms (SNPs) in 17 Th1/Th2 cytokine and related genes in three population-based case-control studies (1,946 cases and 1,808 controls). Logistic regression was used to compute odds ratios (OR) for NHL and four major NHL subtypes in relation to tag SNP genotypes and haplotypes. A gene-based analysis adjusting for the number of tag SNPs genotyped in each gene showed significant associations with risk of NHL combined and one or more NHL subtypes for Th1 (IL12A and IL12RB1) and Th2 (IL4, IL10RB, and IL18) genes. The strongest association was for IL12A rs485497, which plays a central role in bridging the cellular and humoral pathways of innate resistance and antigen-specific adaptive immune responses (allele risk OR=1.17; P(trend)=0.00099). This SNP was also associated specifically with risk of follicular lymphoma (allele risk OR=1.26; P(trend)=0.0012). These findings suggest that genetic variation in Th1/Th2 cytokine genes may contribute to lymphomagenesis.
登录
查看更多内容
影响因子:
2.9
作者:
Murtaugh, Michael P.;Johnson, Craig R.;Zhou, Yaling
通讯作者:
Zhou, Yaling
DOI:
10.1084/jem.20021769
发表时间:
2003-02-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fieschi C;Dupuis S;Catherinot E;Feinberg J;Bustamante J;Breiman A;Altare F;Baretto R;Le Deist F;Kayal S;Koch H;Richter D;Brezina M;Aksu G;Wood P;Al-Jumaah S;Raspall M;Da Silva Duarte AJ;Tuerlinckx D;Virelizier JL;Fischer A;Enright A;Bernhöft J;Cleary AM;Vermylen C;Rodriguez-Gallego C;Davies G;Blütters-Sawatzki R;Siegrist CA;Ehlayel MS;Novelli V;Haas WH;Levy J;Freihorst J;Al-Hajjar S;Nadal D;De Moraes Vasconcelos D;Jeppsson O;Kutukculer N;Frecerova K;Caragol I;Lammas D;Kumararatne DS;Abel L;Casanova JL
通讯作者:
Casanova JL
影响因子:
3.8
作者:
Palmieri, Rachel T.;Wilson, Melanie A.;Schildkraut, Joellen M.
通讯作者:
Schildkraut, Joellen M.
影响因子:
20.3
作者:
Lan, Qing;Zheng, Tongzhang;Chanock, Stephen
通讯作者:
Chanock, Stephen
影响因子:
3.1
作者:
Liu, Yunguang;Lin, Na;Pang, Guangfu
通讯作者:
Pang, Guangfu